Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kura Oncology (KURA) Interest Expenses (2023 - 2025)

Kura Oncology (KURA) has disclosed Interest Expenses for 3 consecutive years, with $346000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Interest Expenses fell 14.14% to $346000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $728000.0, a 55.03% decrease, with the full-year FY2025 number at $1.5 million, down 6.61% from a year prior.
  • Interest Expenses was $346000.0 for Q4 2025 at Kura Oncology, down from $382000.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $412000.0 in Q3 2024 to a low of $346000.0 in Q4 2025.
  • A 3-year average of $389600.0 and a median of $396000.0 in 2023 define the central range for Interest Expenses.
  • Peak YoY movement for Interest Expenses: rose 9.34% in 2024, then decreased 14.14% in 2025.
  • Kura Oncology's Interest Expenses stood at $394000.0 in 2023, then increased by 2.28% to $403000.0 in 2024, then fell by 14.14% to $346000.0 in 2025.
  • Per Business Quant, the three most recent readings for KURA's Interest Expenses are $346000.0 (Q4 2025), $382000.0 (Q1 2025), and $403000.0 (Q4 2024).